OPORF
Price
$0.24
Change
-$0.05 (-17.24%)
Updated
Feb 14 closing price
Capitalization
90.98M
PCSA
Price
$0.24
Change
-$0.01 (-4.00%)
Updated
Jul 25 closing price
Capitalization
6.36M
Interact to see
Advertisement

OPORF vs PCSA

Header iconOPORF vs PCSA Comparison
Open Charts OPORF vs PCSABanner chart's image
OPEN ORPHAN
Price$0.24
Change-$0.05 (-17.24%)
Volume$3K
Capitalization90.98M
Processa Pharmaceuticals
Price$0.24
Change-$0.01 (-4.00%)
Volume$4.19M
Capitalization6.36M
OPORF vs PCSA Comparison Chart in %
Loading...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OPORF vs. PCSA commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPORF is a Hold and PCSA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (OPORF: $0.24 vs. PCSA: $0.24)
Brand notoriety: OPORF and PCSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OPORF: 100% vs. PCSA: 17%
Market capitalization -- OPORF: $90.98M vs. PCSA: $6.36M
OPORF [@Biotechnology] is valued at $90.98M. PCSA’s [@Biotechnology] market capitalization is $6.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPORF’s FA Score shows that 1 FA rating(s) are green whilePCSA’s FA Score has 1 green FA rating(s).

  • OPORF’s FA Score: 1 green, 4 red.
  • PCSA’s FA Score: 1 green, 4 red.
According to our system of comparison, OPORF is a better buy in the long-term than PCSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCSA’s TA Score shows that 4 TA indicator(s) are bullish.

  • PCSA’s TA Score: 4 bullish, 3 bearish.

Price Growth

OPORF (@Biotechnology) experienced а 0.00% price change this week, while PCSA (@Biotechnology) price change was +13.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPORF($91M) has a higher market cap than PCSA($6.36M). OPORF YTD gains are higher at: -34.871 vs. PCSA (-72.528).
OPORFPCSAOPORF / PCSA
Capitalization91M6.36M1,431%
EBITDAN/A-12.09M-
Gain YTD-34.871-72.52848%
P/E Ratio11.75N/A-
RevenueN/A0-
Total CashN/A2.9M-
Total DebtN/A49.7K-
TECHNICAL ANALYSIS
Technical Analysis
OPORFPCSA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
14%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
14%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNR103.080.23
+0.22%
Pentair plc
SMTK0.96N/A
N/A
SmartKem Inc.
PLOW29.25-0.17
-0.58%
Douglas Dynamics
TDTH1.34-0.01
-0.74%
Trident Digital Tech Holdings Ltd
APLS19.59-0.50
-2.49%
Apellis Pharmaceuticals

OPORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPORF has been loosely correlated with KURA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if OPORF jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPORF
1D Price
Change %
OPORF100%
N/A
KURA - OPORF
62%
Loosely correlated
N/A
EVAX - OPORF
53%
Loosely correlated
+0.37%
PCSA - OPORF
51%
Loosely correlated
-3.34%
VERA - OPORF
50%
Loosely correlated
-0.32%
ONCO - OPORF
47%
Loosely correlated
+14.96%
More

PCSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with OPORF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then OPORF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
-3.34%
OPORF - PCSA
51%
Loosely correlated
N/A
INO - PCSA
38%
Loosely correlated
-2.65%
ONCO - PCSA
34%
Loosely correlated
+14.96%
LVTX - PCSA
27%
Poorly correlated
-2.05%
IMNN - PCSA
26%
Poorly correlated
-7.24%
More